Product custom-nanocomposites-lipid-nanoparticle-composite-materials

Home > products > custom-nanocomposites> lipid-nanoparticle-composite-materials

Catalog	name	Description	price
R-Mcs-562	NH2-PEG2k-RVG29 modified black phosphorus nanosheets@metformin hydrochloride,±100nm	NH2-PEG2k-RVG29 modified black phosphorus nanosheets @metformin hydrochloride,±100nm is an intelligent nano delivery system for the treatment of brain diseases. It combines the photothermal properties of black phosphorus, enhanced PEGylation stability, and the neural targeting ability of RVG29 peptide segment to achieve precise drug delivery in the central nervous system.	price>
R-Mcs-571	Liposomal nanoparticles@zoledronic acid surface modified with mannose,±100nm	Liposomal nanoparticles@zoledronic acid surface modified with mannose,±100nm/Liposomal nanoparticles loaded with zoledronic acid surface modified with mannose is a multifunctional liposome nanoparticle carrier that combines bone targeting and immunomodulatory potential.	price>
R-Mcs-572	FA@MoSe2@TA-Cu(copper tannate)	FA@MoSe2@TA-Cu(copper tannate)/FA-MoSe2@TA-Cu(copper tannate)/FA modified MoSe2 nanoflowers loaded with copper tannate (TA-Cu)/Folic acid modifiedMolybdenumselenide(MoSe2) nanoflowers loaded with copper tannate is a composite nano functional material. This material is generally used in tumor synergistic therapy research, combining multiple advantages of targeting ability, catalytic therapy, and copper death therapy.	price>
R-Mcs-578	HSA-Ca3(PO4)2@FePt nanoparticles	HSA-Ca3(PO4)2@FePt nanoparticles/Human serum albumin-calcium phosphate coated FePt nanoparticles/HSA-calcium phosphate coated FePt nanoparticles are composite nanoparticles that belong to the functional nanomaterials of multimodal diagnosis and treatment integration, and are commonly used in the diagnosis and treatment research of tumors.	price>
R-Mcs-582	H-MnO2-PEG5K@Auranofin,100-150nm	Hollow manganese dioxide-PEG5000@Auranofin,100-150nm/PEG5k-Hollow manganese dioxide@Auranofin,100-150nm/PEG5000-Hollow manganese dioxide@Auranofin,100-150nm/Polyethylene glycol 5k modified hollow manganese dioxide coated Auranofin,100-150nm is a functional nano drug delivery system aimed at the field of tumor therapy.	price>
R-Mcs-583	CY5.5-blank liposome surface modified RGD	CY5.5 blank liposome surface modified RGD/CY5.5 modified blank liposome surface modified RGD is an integrin targeted near-infrared fluorescent labeled blank liposome. As a blank control probe, it intuitively tracks the complete dynamic process of blood circulation, tissue distribution, and tumor enrichment of targeted liposomes in vivo, and is used to evaluate the in vivo behavior of a novel liposome delivery system. Based on the near-infrared fluorescence characteristics of CY5.5 and the tumor targeting ability of RGD, high signal-to-noise ratio in vivo tumor imaging can be achieved to accurately locate the growth and metastasis sites of tumors.	price>
R-GHLS-100NM	Calcein Liposome （100nm）	Calcein Liposome from ruixi.Compared with the aqueous solution of calcein, the liposome can greatly increase the amount of calcein in the passive transmembrane, which is mainly distributed in lysosomes. The small molecule water-soluble drugs can change the way of entering cells, improve the ability of entering cells and affect the intracellular distribution.	price>
R-R-5665	HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide (50/45/4/1, mol/mol) Liposomes	HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide (50/45/4/1, mol/mol) Liposomes. PEGylated liposomes containing free maleimide functional group for maleimide-thiol conjugation. The liposomes are co-formulated with 1 mol% DSPE-mPEG2000-maleimide, and supplied in a pH-optimized buffer for direct conjugation of the thiol-containing molecule of choice. Conjugation can be achieved by incubating the liposomes with the activated thiol-containing compound which has been reduced by a disulfide bond reducing agent such as (tris(2-carboxyethyl)phosphine) (TCEP), which can be purchased as an add-on.	price>
R-R-5666	Tanespimycin (17-AAG) Liposomes, Formulation XT28.1	Tanespimycin (17-AAG) Liposomes, Formulation XT28.1. PEGylated liposomes containing Hsp90 inhibitor Tanespimycin (17-AAG). Tanespimycin exhibits 100-fold higher binding affinity to HSP90 derived from tumor cells vs normal cells, and induces apoptosis, necrosis, autophagy, and mitophagy. Tanespimycin is insoluble in aqueous media. This product is a pre-formulated liposomal version of Tanespimycin which is supplied ready to use in vitro or in vivo. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.	price>
R-R-5667	DT-061 (SMAP) Liposomes, Formulation TT-40	DT-061 (SMAP) Liposomes, Formulation TT-40. PEGylated liposomes containing PP2A activator DT-061 (SMAP). DT-061 is an activator of protein phosphatase 2A (PP2A). PP2A regulates many cellular signaling pathways including MAPK/ERK, Wnt/β-catenin, Akt/mTOR, GSK3β, p53/apoptosis, cell cycle, and others. This product can be used in vitro or in vivo for studying the effects of PP2A activation and could be applied to preclinical therapy of KRAS-mutant and MYC-driven tumors. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.	price>

...